Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Apyx Medical ( (APYX) ).
On August 7, 2025, Apyx Medical Corporation held its annual stockholders meeting where several key proposals were voted on. The stockholders elected five directors, ratified RSM US LLP as the independent accounting firm for 2025, approved executive compensation resolutions, and amended the company’s Certificate of Incorporation. These decisions are expected to influence the company’s governance and operational strategies moving forward.
The most recent analyst rating on (APYX) stock is a Buy with a $4.00 price target. To see the full list of analyst forecasts on Apyx Medical stock, see the APYX Stock Forecast page.
Spark’s Take on APYX Stock
According to Spark, TipRanks’ AI Analyst, APYX is a Neutral.
Apyx Medical’s overall stock score reflects a mix of challenges and opportunities. The most significant factor is the weak financial performance, with ongoing losses and cash flow issues. However, the positive sentiment from the earnings call, driven by the AYON system launch and cost reductions, provides some optimism. Technical indicators suggest moderate upward momentum, but valuation concerns remain due to the negative P/E ratio.
To see Spark’s full report on APYX stock, click here.
More about Apyx Medical
Apyx Medical Corporation operates in the medical technology industry, focusing on the development and commercialization of innovative medical devices. The company is known for its advanced energy solutions that are utilized in surgical and aesthetic procedures, aiming to enhance patient outcomes and improve healthcare delivery.
Average Trading Volume: 94,746
Technical Sentiment Signal: Buy
Current Market Cap: $84.72M
For an in-depth examination of APYX stock, go to TipRanks’ Overview page.